XML 31 R61.htm IDEA: XBRL DOCUMENT v2.4.0.6
Other Operating Expense Net (Restructuring Costs and Reserve Details) (Details) (USD $)
 3 Months Ended
Mar. 29, 2013
Mar. 30, 2012
Restructuring Cost and Reserve [Line Items]    
Proceeds from sale of orthopaedic product lines $ 1,768,000 $ 0
Orthopaedic Facility Optimization [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Activities, Description  In 2010, the Company began updating its Indianapolis, IN facility to streamline operations, consolidate two buildings, increase capacity, further expand capabilities and reduce dependence on outside suppliers. This initiative was completed in 2011.          In 2011, the Company began construction on an orthopaedic manufacturing facility in Fort Wayne, IN and transferred the manufacturing operations being performed at its Columbia City, IN facility into this new facility. This initiative was completed in 2012. During 2012, the Company transferred most functions performed at its facilities in Orvin and Corgemont, Switzerland into existing facilities in Fort Wayne, IN and Tijuana, Mexico. In connection with this consolidation, in 2012, the Company entered into an agreement to sell certain non-core Swiss orthopaedic product lines to an independent third party which included the inventory, machinery, equipment, customer lists and technology related to these product lines. As these product lines were considered a business, goodwill was allocated to the transaction. As these product lines did not have cash flows that were clearly distinguishable, both operationally and for financial reporting purposes, from the rest of the Company, they were not considered discontinued operations. This transaction closed in the first quarter of 2013 and no additional loss on sale was recognized. During the first quarter of 2013, the Company received $1.8 million in connection with this transaction and the third party assumed $2.4 million of severance liabilities.  
Restructuring Initiation Date 2010  
Restructuring And Related Activities Capital Expenditures Incurred To Date 21,200,000  
Restructuring and Related Cost, Cost Incurred to Date 35,800,000  
Liabilities Assumed By Third Parties (2,398,000)  
Orthopaedic Facility Optimization [Member] | Severance And Retention [Member]
    
Restructuring Cost and Reserve [Line Items]    
Liabilities Assumed By Third Parties (2,398,000)  
Orthopaedic Facility Optimization [Member] | Accelerated Depreciation And Asset Write Offs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Liabilities Assumed By Third Parties 0  
Orthopaedic Facility Optimization [Member] | Other Restructuring [Member]
    
Restructuring Cost and Reserve [Line Items]    
Liabilities Assumed By Third Parties 0  
Orthopaedic Facility Optimization [Member] | Minimum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 25,000,000  
Restructuring and Related Cost, Expected Cost 36,000,000  
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Severance And Retention [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 12,000,000  
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Accelerated Depreciation And Asset Write Offs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 15,000,000  
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Other Restructuring [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 9,000,000  
Orthopaedic Facility Optimization [Member] | Maximum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 30,000,000  
Restructuring and Related Cost, Expected Cost 40,000,000  
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Severance And Retention [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 13,000,000  
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Accelerated Depreciation And Asset Write Offs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 16,000,000  
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Other Restructuring [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 11,000,000  
Medical Device Facility Optimization [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Activities, Description Near the end of 2011, the Company initiated plans to upgrade and expand its manufacturing infrastructure in order to support its medical device strategy. This includes the transfer of certain product lines to create additional capacity for the manufacture of medical devices, expansion of two existing facilities, as well as the purchase of equipment to enable the production of medical devices. These initiatives are expected to be completed over the next two years.  
Restructuring Initiation Date 2011  
Restructuring And Related Activities Capital Expenditures Incurred To Date 10,300,000  
Restructuring and Related Cost, Cost Incurred to Date 1,600,000  
Medical Device Facility Optimization [Member] | Other Restructuring [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 1,000,000  
Medical Device Facility Optimization [Member] | Minimum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 15,000,000  
Restructuring and Related Cost, Expected Cost 2,000,000  
Medical Device Facility Optimization [Member] | Minimum [Member] | Production Inefficiencies, Moving And Revalidation [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 500,000  
Medical Device Facility Optimization [Member] | Minimum [Member] | Personnel [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 1,000,000  
Medical Device Facility Optimization [Member] | Maximum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 20,000,000  
Restructuring and Related Cost, Expected Cost 3,000,000  
Medical Device Facility Optimization [Member] | Maximum [Member] | Production Inefficiencies, Moving And Revalidation [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 1,000,000  
Medical Device Facility Optimization [Member] | Maximum [Member] | Personnel [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 1,500,000  
ERP System Upgrade [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Activities, Description In 2011, the Company initiated plans to upgrade its existing global ERP system. This initiative is expected to be completed over the next year.  
Restructuring Initiation Date 2011  
Restructuring And Related Activities Capital Expenditures Incurred To Date 3,000,000  
Restructuring and Related Cost, Cost Incurred to Date 5,300,000  
ERP System Upgrade [Member] | Minimum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 4,000,000  
Restructuring and Related Cost, Expected Cost 6,000,000  
ERP System Upgrade [Member] | Minimum [Member] | Training And Consulting Costs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 4,000,000  
ERP System Upgrade [Member] | Minimum [Member] | Accelerated Depreciation And Asset Write Offs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 2,000,000  
ERP System Upgrade [Member] | Maximum [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring And Related Activities Expected Capital Expenditures 5,000,000  
Restructuring and Related Cost, Expected Cost 7,000,000  
ERP System Upgrade [Member] | Maximum [Member] | Training And Consulting Costs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost 4,500,000  
ERP System Upgrade [Member] | Maximum [Member] | Accelerated Depreciation And Asset Write Offs [Member]
    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost $ 2,500,000